On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Tinnitus Severity Linked to Mood, Sleep, and Personality
Tinnitus affects approximately 10 percent of the U.S. adult population and 14 percent of the world’s population (NIDCD, 2025). Tinnitus can sound different to individuals,…
Academy Board of Directors Meets with Lawmakers During Government Shutdown
On October 23, the Academy Board of Directors held a successful Hill Day in Washington, D.C. amid the federal government shutdown. The Academy is deeply…
Influence of the Electrical Dynamic Range (EDR) on Speech Perception, Vocabulary, and Quality of Life in Young Children
A person’s electrical dynamic range (EDR) in a cochlear implant (CI) is defined as the difference between the highest tolerable current level, without discomfort or…
